These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Errors introduced by tissue heterogeneity in estimation of local cerebral glucose utilization with current kinetic models of the [18F]fluorodeoxyglucose method. Schmidt K; Lucignani G; Moresco RM; Rizzo G; Gilardi MC; Messa C; Colombo F; Fazio F; Sokoloff L J Cereb Blood Flow Metab; 1992 Sep; 12(5):823-34. PubMed ID: 1506447 [TBL] [Abstract][Full Text] [Related]
43. Intersubject variability of brain glucose metabolic measurements in young normal males. Wang GJ; Volkow ND; Wolf AP; Brodie JD; Hitzemann RJ J Nucl Med; 1994 Sep; 35(9):1457-66. PubMed ID: 8071692 [TBL] [Abstract][Full Text] [Related]
44. Effect of vascular activity in the determination of rate constants for the uptake of 18F-labeled 2-fluoro-2-deoxy-D-glucose: error analysis and normal values in older subjects. Evans AC; Diksic M; Yamamoto YL; Kato A; Dagher A; Redies C; Hakim A J Cereb Blood Flow Metab; 1986 Dec; 6(6):724-38. PubMed ID: 3491827 [TBL] [Abstract][Full Text] [Related]
45. Cerebral glucose metabolic differences in patients with panic disorder. Nordahl TE; Semple WE; Gross M; Mellman TA; Stein MB; Goyer P; King AC; Uhde TW; Cohen RM Neuropsychopharmacology; 1990 Aug; 3(4):261-72. PubMed ID: 2400544 [TBL] [Abstract][Full Text] [Related]
52. Viability of neocortical function shown in behavioral activation state PET studies in Alzheimer disease. Duara R; Barker WW; Chang J; Yoshii F; Loewenstein DA; Pascal S J Cereb Blood Flow Metab; 1992 Nov; 12(6):927-34. PubMed ID: 1400646 [TBL] [Abstract][Full Text] [Related]
53. Measurement of the ratio of cerebral oxygen consumption to glucose utilization by positron emission tomography: its consistency with the values determined by the Kety-Schmidt method in normal volunteers. Hatazawa J; Ito M; Matsuzawa T; Ido T; Watanuki S J Cereb Blood Flow Metab; 1988 Jun; 8(3):426-32. PubMed ID: 3259242 [TBL] [Abstract][Full Text] [Related]
54. Reproducibility of cerebral glucose metabolic measurements in resting human subjects. Bartlett EJ; Brodie JD; Wolf AP; Christman DR; Laska E; Meissner M J Cereb Blood Flow Metab; 1988 Aug; 8(4):502-12. PubMed ID: 3260593 [TBL] [Abstract][Full Text] [Related]
55. The use of spectral analysis to determine regional cerebral glucose utilization with positron emission tomography and [18F]fluorodeoxyglucose: theory, implementation, and optimization procedures. Turkheimer F; Moresco RM; Lucignani G; Sokoloff L; Fazio F; Schmidt K J Cereb Blood Flow Metab; 1994 May; 14(3):406-22. PubMed ID: 8163583 [TBL] [Abstract][Full Text] [Related]
56. Regional cerebral glucose metabolism in man during wakefulness, sleep, and dreaming. Heiss WD; Pawlik G; Herholz K; Wagner R; Wienhard K Brain Res; 1985 Feb; 327(1-2):362-6. PubMed ID: 3872693 [TBL] [Abstract][Full Text] [Related]
57. Differences in lateral hemispheric asymmetries of glucose utilization between early- and late-onset Alzheimer-type dementia. Koss E; Friedland RP; Ober BA; Jagust WJ Am J Psychiatry; 1985 May; 142(5):638-40. PubMed ID: 3872604 [TBL] [Abstract][Full Text] [Related]
58. Stability of resting deoxyglucose metabolic values in PET studies of schizophrenia. Bartlett EJ; Barouche F; Brodie JD; Wolkin A; Angrist B; Rotrosen J; Wolf AP Psychiatry Res; 1991 May; 40(1):11-20. PubMed ID: 1946838 [TBL] [Abstract][Full Text] [Related]
59. Glucose utilization rate versus brain size in humans. Hatazawa J; Brooks RA; Di Chiro G; Bacharach SL Neurology; 1987 Apr; 37(4):583-8. PubMed ID: 3494211 [TBL] [Abstract][Full Text] [Related]
60. The metabolic pathology of the AIDS dementia complex. Rottenberg DA; Moeller JR; Strother SC; Sidtis JJ; Navia BA; Dhawan V; Ginos JZ; Price RW Ann Neurol; 1987 Dec; 22(6):700-6. PubMed ID: 3501695 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]